​

HeartBeam Stock (NASDAQ:BEAT)

ForecastOwnershipFinancialsChartTranscripts
HeartBeam by TradingView

Previous Close

$0.40

52W Range

$0.35 - $4.00

50D Avg

$0.44

200D Avg

$0.91

Market Cap

$22.16M

Avg Vol (3M)

$7.24M

Beta

-0.77

Div Yield

-

BEAT Company Profile

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Show More

Industry

Medical - Specialties

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

16

IPO Date

Nov 16, 2021

Website

BEAT Performance

BEAT Financial Summary

Dec 25Dec 24Dec 23
Revenue---
Operating Income$-21.14M$-19.89M$-15.31M
Net Income$-21.02M$-19.45M$-14.64M
EBITDA$-21.14M$-19.88M$675.00K
Basic EPS$-0.62$-0.73$-0.72
Diluted EPS$-0.62$-0.73$-0.72

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 26Aug 13, 26 | 4:30 PM
Q1 26May 13, 26 | 4:30 PM
Q4 25Mar 12, 26 | 4:30 PM

Peer Comparison

TickerCompany
SPRBSpruce Biosciences, Inc.
OSTXOS Therapies Incorporated
MDAISpectral AI, Inc.
EQEquillium, Inc.
OTLKOutlook Therapeutics, Inc.
HOWLWerewolf Therapeutics, Inc.
CRVOCervoMed Inc.
INKTMiNK Therapeutics, Inc.
IOBTIO Biotech, Inc.
ONMDOneMedNet Corporation